Prospects for population screening and diagnosis of lung cancer

The Lancet

Volumn 382, Issue 9893, 2013, Pages 732-741

  Field, John K ^a   Oudkerk, Matthijs ^b   Pedersen, Jesper Holst ^c   Duffy, Stephen W ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MASS SCREENING; PRIORITY JOURNAL; SMOKING CESSATION; THORAX RADIOGRAPHY;

EID: 84882943447     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61614-1     Document Type: Review

References (68)

1. R Peto, AD Lopez, J Boreham, M Thun, C Heath Jr, R Doll The global smoking epidemic Br Med Bull 52 1996 12 21
2. R Lozano, M Naghavi, K Foreman et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 2095 2128
3. P Zhao, M Dai, W Chen, N Li Cancer trends in China Jpn J Clin Oncol 40 2010 281 285
4. Office for National Statistics Cancer survival in England: patients diagnosed 2005-2009 and followed up to 2010 2011 Office for National Statistics London
5. S Walters, C Maringe, MP Coleman et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden, and the UK: a population-based study, 2004-2007 Thorax 68 2013 551 564
6. M Santarpia, G Altavilla, MF Salazar et al. Tyrosine kinase inhibitors for non-small-cell lung cancer: finding patients who will be responsive Expert Rev Respir Med 5 2011 413 424
7. A van Baardwijk, WA Tome, W van Elmpt et al. Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review Radiother Oncol 105 2012 145 149
8. E Vallieres, S Peters, P Van Houtte, P Dalal, E Lim Therapeutic advances in non-small cell lung cancer Thorax 67 2012 1097 1101
9. National Lung Screening Trial Research Team DR Aberle, AM Adams et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 2011 395 409
10. MM Oken, WG Hocking, PA Kvale et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial JAMA 306 2011 1865 1873
11. U Pastorino, M Bellomi, C Landoni et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results Lancet 362 2003 593 597
12. M Infante, FR Lutman, S Cavuto et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial Lung Cancer 59 2008 355 363
13. T Blanchon, JM Brechot, PA Grenier et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR) Lung Cancer 58 2007 50 58
14. A Lopes Pegna, G Picozzi, M Mascalchi et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT Lung Cancer 64 2009 34 40
15. RJ van Klaveren, M Oudkerk, M Prokop et al. Management of lung nodules detected by volume CT scanning N Engl J Med 361 2009 2221 2229
16. J Pedersen, H Ashraf, A Dirksen et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round J Thorac Oncol 5 2009 608 614
17. N Becker, E Motsch, ML Gross et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round J Cancer Res Clin Oncol 138 2012 1475 1486
18. DR Baldwin, SW Duffy, NJ Wald, R Page, DM Hansell, JK Field UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer Thorax 66 2011 308 313
19. M Infante, S Cavuto, F Lutman et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial Am J Respir Crit Care Med 180 2009 445 453
20. U Pastorino, M Rossi, V Rosato et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial Eur J Cancer Prev 21 2012 308 315
21. Field J, van Klaveren R, Pedersen J, et al. European randomised lung cancer screening trials: post NLST. J Surg Oncol (in press).
22. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version 1, 2012.
23. National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology: lung cancer screening. Version 1 http://www.respiratory-thessaly. gr/assets/lung-screening%201.2013.pdf 2013 (accessed Aug 7, 2013).
24. American Lung Association Providing guidance on lung cancer screening to patients and physicians http://www.lung.org/lung-disease/lung-cancer/lung- cancer-screening-guidelines/lung-cancer-screening.pdf April 23, 2012 (accessed Aug 7, 2013).
25. R Siegel, E Ward, O Brawley, A Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
26. MT Jaklitsch, FL Jacobson, JH Austin et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups J Thorac Cardiovasc Surg 144 2012 33 38
27. R Wender, ETH Fontham, E Barrera Jr American Cancer Society lung cancer screening guidelines CA Cancer J Clin 63 2013 107 117
28. JK Field, RA Smith, DR Aberle et al. International Association for the Study of Lung Cancer computed tomography screening workshop 2011 report J Thorac Oncol 7 2012 10 19
29. A Cassidy, JP Myles, T Liloglou, SW Duffy, JK Field Defining high-risk individuals in a population-based molecular-epidemiological study of lung cancer Int J Oncol 28 2006 1295 1301
30. PB Bach, MW Kattan, MD Thornquist et al. Variations in lung cancer risk among smokers J Natl Cancer Inst 95 2003 470 478
31. A Cassidy, JP Myles, M van Tongeren et al. The LLP risk model: an individual risk prediction model for lung cancer Br J Cancer 98 2008 270 276
32. OY Raji, SW Duffy, OF Agbaje et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study Ann Intern Med 157 2012 242 250
33. MR Spitz, WK Hong, CI Amos et al. A risk model for prediction of lung cancer J Natl Cancer Inst 99 2007 715 726
34. CJ Etzel, S Kachroo, M Liu et al. Development and validation of a lung cancer risk prediction model for African-Americans Cancer Prev Res 1 2008 255 265
35. CM Tammemagi, PF Pinsky, NE Caporaso et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation J Natl Cancer Inst 103 2011 1058 1068
36. C Hoggart, P Brennan, A Tjonneland et al. A risk model for lung cancer incidence Cancer Prev Res 5 2012 834 846
37. P Maisonneuve, V Bagnardi, M Bellomi et al. Lung cancer risk prediction to select smokers for screening CT - a model based on the Italian COSMOS trial Cancer Prev Res 4 2011 1778 1789
38. J Peres Lung cancer screening gets risk-specific J Natl Cancer Inst 105 2013 1 2
39. MC Tammemagi, HA Katki, WG Hocking et al. Selection criteria for lung-cancer screening N Engl J Med 368 2013 728 736
40. S Lam, M Tsao Early detection of lung cancer: a pan-Canadian study http://www.tfri.ca/programs/institute-2008-01.asp 2008 (accessed Aug 7, 2013).
41. DR Aberle, CD Berg, WC Black et al. The National Lung Screening Trial: overview and study design Radiology 258 2011 243 253
42. CA van Iersel, HJ de Koning, G Draisma et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON) Int J Cancer 120 2007 868 874
43. M Hassanein, JC Callison, C Callaway-Lane, MC Aldrich, EL Grogan, PP Massion The state of molecular biomarkers for the early detection of lung cancer Cancer Prev Res 5 2012 992 1006
44. OY Raji, OF Agbaje, SW Duffy, A Cassidy, JK Field Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project Cancer Prev Res 3 2010 664 669
45. MR Spitz, CI Amos, S Land et al. Role of selected genetic variants in lung cancer risk in African Americans J Thorac Oncol 8 2013 391 397
46. SC Van't Westeinde, RJ van Klaveren Screening and early detection of lung cancer Cancer J 17 2011 3 10
47. AA Bankier, HY Kressel Through the looking glass revisited: the need for more meaning and less drama in the reporting of dose and dose reduction in CT Radiology 265 2012 4 8
48. N Horeweg, CM van der Aalst, E Thunnissen et al. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial Am J Respir Crit Care Med 187 2013 848 854
49. X Xie, Y Zhao, RA Snijder et al. Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study Eur Radiol 23 2013 139 147
50. CI Henschke, R Yip, DF Yankelevitz, JP Smith Definition of a positive test result in computed tomography screening for lung cancer: a cohort study Ann Intern Med 158 2013 246 252
51. PB Bach, JN Mirkin, TK Oliver et al. Benefits and harms of CT screening for lung cancer: a systematic review JAMA 307 2012 2418 2429
52. MA Heuvelmans, M Oudkerk, GH de Bock et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals Eur Radiol 23 2013 1836 1845
53. HJ Lim, S Ahn, KS Lee et al. Persistent pure ground-glass opacity lung nodules >/= 10 mm in diameter at ct: histopathologic comparisons and prognostic implications Chest 2013 10.1378/chest.12-2987 published online May 30.
54. Centers for Disease Control and Prevention Cigarette smoking among adults - United States, 2006 MMWR Morb Mortal Wkly Rep 56 2007 1157 1161
55. Chang B, Hwang J, Choi Y, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest; 143: 172-78.
56. DP Naidich, AA Bankier, H MacMahon et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society Radiology 266 2013 304 317
57. RH Petersen, HJ Hansen, A Dirksen, JH Pedersen Lung cancer screening and video-assisted thoracic surgery J Thorac Oncol 7 2012 1026 1031
58. H Hansen, R Petersen Video-assisted thoracoscopic lobectomy using a standardized three-port anterior approach - the Copenhagen experience Ann Cardiothorac Surg 1 2012 70 76
59. BS Pyenson, MS Sander, Y Jiang, H Kahn, JL Mulshine An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost Health Aff 31 2012 770 779
60. B Whitson, S Groth, S Duval, S Swanson, M Maddaus Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy Ann Thorac Surg 86 2008 2008 2016
61. S Paul, N Altorki, S Sheng Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database J Thorac Cardiovasc Surg 139 2010 366 378
62. K Nakamura, H Saji, R Nakajima et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L) Jpn J Clin Oncol 40 2010 271 274
63. E Lim, D Baldwin, M Beckles et al. Guidelines on the radical management of patients with lung cancer Thorax 65 suppl 3 2010 iii1 ii27
64. S Senan, M Paul, F Lagerwaard Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? Lancet Oncol 14 2013 270 274
65. M Ambrogi, O Fanucchi, R Cioni Long-term results of radiofrequency ablation treatment of stage I non-small cell lung cancer: a prospective intention-to-treat study Thorac Oncol 6 2011 2044 2051
66. Field J, Baldwin D, Devaraj A, et al. United Kingdom lung cancer screening trial (UKLS): first 88897 approaches. American Association for Cancer Research Annual Meeting 2013; Washington, DC, USA; April 6-10, 2013. Abstract 3631.
67. CR Chien, TH Chen Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography Int J Cancer 122 2008 2594 2599
68. LL Humphrey, M Deffebach, M Pappas et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation Ann Intern Med 2013 10.7326/0003-4819-159-6- 201309170-00690 published online July 30.